AT1 and AT2-receptor antagonists inhibit Ang II-mediated facilitation of noradrenaline release in human atria

Journal of Cardiovascular Pharmacology
Malek El MuayedL C Rump


It is generally accepted that regulation of blood pressure and sympathetic neurotransmission by angiotensin (Ang) II is brought about through activation of AT1-receptors. Since recent studies demonstrated a high proportion of AT2-receptors in the human heart, the aim of our study was to investigate whether Ang II modulates noradrenaline release also through activation of AT2-receptors in this tissue. Human atrial appendages were prelabeled with [3H]-noradrenaline and electrically field-stimulated. Stimulation-induced outflow of radioactivity was taken as an index of endogenous noradrenaline release. Ang I and II enhanced noradrenaline release in a dose-dependent manner up to 55 and 72%, respectively. These effects were blocked by the selective AT1-receptor antagonists EXP3174 and irbesartan (10 nmol/L). Moreover, the selective AT2-receptor antagonists PD123319 and CGP42112A (0.1 and 1 micromol/L) also inhibited Ang II-induced facilitation of noradrenaline release. Captopril (5 micromol/L) shifted the dose response curve for Ang I less potent to the right than EXP3174 (10 nmol/L). Ang I and II enhanced the stimulation-induced noradrenaline release significantly more potent in tissues of patients pretreated with ACE inhibitors th...Continue Reading


Jan 1, 1982·Annual Review of Pharmacology and Toxicology·M J Antonaccio
Dec 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·I PörstiR Busse
May 1, 1995·Hypertension·M de GasparoP B Timmermans
Mar 21, 1998·Lancet·L C RumpP Schollmeyer
Apr 8, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·L C Rump
Jun 26, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M Haugh, D Fouque
Aug 27, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·L C RumpE Schwertfeger
Feb 15, 2001·Circulation·M Burnier
Jun 20, 2001·American Journal of Hypertension·T E Lohmeier
Aug 17, 2001·The Journal of Biological Chemistry·S AbdAllaU Quitterer
Sep 22, 2001·Hypertension·S A MezzanoJ Egido
Mar 7, 2002·American Journal of Physiology. Cell Physiology·Catherine ChassagneSylvain Meloche
Mar 15, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Yi XuBodh I Jugdutt
Sep 7, 2002·Hypertension·Andreas DendorferPeter Dominiak

❮ Previous
Next ❯


Sep 28, 2004·Naunyn-Schmiedeberg's Archives of Pharmacology·Serafim GuimarãesDaniel Moura
Aug 12, 2005·Journal of Hypertension·Johannes StegbauerLars Christian Rump
Aug 2, 2008·Journal of Cardiovascular Pharmacology·Tetsumasa SasaokaYasuo Matsumura
Oct 7, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Mirnela BykuThomas C Westfall
Jul 16, 2011·Regulatory Peptides·S A PotthoffO Vonend
Oct 12, 2010·Journal of Molecular and Cellular Cardiology·Neil HerringDavid J Paterson
Jul 22, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Niwanthi W RajapakseRoger G Evans
May 8, 2019·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Fumiko YamakiYoshio Tanaka

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.